Nutritional Status and Intake in Patients With Non-cystic Fibrosis Bronchiectasis (NCFB)
Launched by UNIVERSITY OF LEEDS · Mar 13, 2025
Trial Information
Current as of April 22, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • People who have a confirmed diagnosis of NCFB
- • people with NCFB who are clinically stable (not requiring acute admission to hospital)
- • people who attend the regional clinic
- Exclusion Criteria:
- • People who are pregnant
- • people with existing comorbidities such as malignancy
About University Of Leeds
The University of Leeds is a prestigious research institution located in the United Kingdom, renowned for its commitment to advancing knowledge through innovative research and education. As a clinical trial sponsor, the University of Leeds leverages its diverse expertise and collaborative environment to facilitate high-quality clinical studies that aim to improve health outcomes and contribute to the scientific community. The university fosters interdisciplinary partnerships, ensuring rigorous methodologies and ethical standards in its research initiatives. By integrating cutting-edge technologies and a patient-centered approach, the University of Leeds plays a vital role in translating research findings into practical applications for healthcare improvement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leeds, West Yorkshire, United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
